The Israeli Start-Up Ecosystem: Advanced Technology, Chutzpah, and the Military

Wednesday, March 11, 2015

Source: EMDT

After an accident in 1997 left him a quadriplegic, scientist Amit Goffer refused to accept the fact that, at the end of the 20th century, there were no alternative solutions to a wheelchair available. Driven by that personal and potential patient demand, the Israeli engineer began working on a robotic exoskeleton with powered leg attachments designed to help paralysed patients to stand upright and walk again. He founded the start-up Re-Walk to bring his device to market, and in June 2014, the company obtained FDA clearance for the device; in September, the company went public on NASDAQ, raising $36 million. 

The origin of Re-Walk is one of many success stories illustrating how Israeli start-up companies have applied cutting-edge technologies to medical problems. But there are many more: The Technion Institute of Technology developed the nanotechnology device NaNose to detect different types of cancer from a patient’s breath with up to 95% accuracy, for example. The start-up IceCure, on the other hand, devised a method for freezing small tumors that eliminates the need for surgery. And Real View’s technology projects 3-D ultrasound holograms above patients in the surgical theater to guide physicians during operations. The list goes on.

Over the last few decades, Israel has earned the title of ‘start-up nation,’ thanks to its staggering statistic of spawning one new company for every 1800 people—by far the highest rate in the world. According to the consultancy Deloitte, almost 1000 start-ups are launched every year in the country.

At first glance, it is not easy to understand how a country with a tiny market is able to establish such a vivacious start-up ecosystem. The business intelligence company Business Monitor International (BMI) estimates the Israeli medical device market at $1,077.4 million in 2013, for instance. “The market is expected to grow at a CAGR of 9.5%, which should see it reach a value of US$1,692.8 million in 2018,” Glen Peters, medical devices market analyst at BMI told EMDT. “Broken down by product area, performance is expected to range from 7.2% for diagnostic imaging to 16.8% for orthopaedics and prosthetics.” Because the country is politically isolated from neighboring Arab countries, the EU, China and the United States serve as vital trade partners for Israel.

View All News »